BrainsWay logo
BrainsWay
BWAY | NASDAQ
Chart Builder DCF Calculator
$9.39
-$0.72 (-7.12%)
At close: Nov 16, 2026, 4:00 PM ET
$9.39
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

BrainsWay Company Profile

Company profile explained

Company Profile

BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's clientele primarily comprises medical professionals, hospitals, and medical centers specializing in psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Key Executives

Name Position
Hadar Levy Chief Executive Officer
Gilead Moiseyev Chief Technology Officer
Ido Marom Chief Financial Officer
Naomi Rozenfeld Chief Marketing Officer
Abraham Zangen Co-Founder, Member of Scientific Advisory Board & Director
Colleen Hanlon Vice President of Medical Affairs
David Zacut Co-Founder & Vice-Chairman
Dor Hagai Vice President of Operations
Menachem C. Klein Vice President, General Counsel & Corporate Secretary
Michael Cohen Vice President of US Sales
Yiftach Roth Founder & Chief Scientific Officer

Latest SEC Filings

Date Type Title
Oct 26, 2026 6-K/A [Amend] Filing
Oct 26, 2026 6-K Filing
Oct 21, 2026 6-K Filing
Oct 19, 2026 6-K Filing
Oct 13, 2026 6-K Filing
Sep 29, 2026 6-K Filing
Sep 08, 2026 6-K Filing
Aug 27, 2026 6-K Filing
Aug 12, 2026 6-K Filing
Aug 12, 2026 6-K Filing
View All SEC Filings ➞
BrainsWay
BrainsWay logo
Country Israel
IPO Date Apr 17, 2019
Industry Medical - Specialties
Sector Healthcare
Employees 129
CEO Hadar Levy

Contact Details

16 Hartum St Jerusalem, JM 9777516 Israel

Stock Details

Ticker Symbol BWAY
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001505065
CUSIP Number 10501L106
ISIN Number US10501L1061
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.